Literature DB >> 6738598

Ornithine decarboxylase as a biologic marker in familial colonic polyposis.

G D Luk, S B Baylin.   

Abstract

We investigated whether the activity of ornithine decarboxylase might serve as a diagnostic test for detecting the presence of the genotype for familial polyposis. This rate-limiting enzyme in the polyamine biosynthetic pathway is essential for intestinal mucosal proliferation. In colonic mucosa from 16 normal controls, ornithine decarboxylase activity was less than 2.5 nmol per milligram per hour. In contrast, it was higher than 2.5 nmol per milligram per hour in the normal-appearing areas of colonic mucosa from 11 of 13 patients with familial polyposis and in all polyps biopsied from these same subjects (P less than 0.05 for specimens from both sites, as compared with controls). Mucosa from dysplastic polyps showed higher mean ornithine decarboxylase activity than mucosa from polyps that were not dysplastic (P less than 0.05). In colonic mucosa from clinically unaffected, first-degree relatives of patients with familial polyposis, there was a bimodal distribution of ornithine decarboxylase activity, with one peak at the mean for normal controls and the other near the mean for normal-appearing mucosa from affected patients. Our study suggests that ornithine decarboxylase activity in colonic mucosa may reflect the abnormal proliferative state in familial polyposis and identify clinically normal family members who carry the genotype.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738598     DOI: 10.1056/NEJM198407123110202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

1.  Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells.

Authors:  J A Moshier; D L Osborne; M Skunca; J Dosescu; J D Gilbert; M C Fitzgerald; G Polidori; R L Wagner; S J Friezner Degen; G D Luk
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

2.  Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection.

Authors:  S E Patchett; P H Katelaris; Z W Zhang; E M Alstead; P Domizio; M J Farthing
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

Review 3.  Polyamines in gastrointestinal cancer.

Authors:  R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

Review 4.  The chemotherapeutic potential of polyamine antimetabolites.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

5.  Increase in ornithine decarboxylase activity associated with development of dysplasia in Barrett's esophagus.

Authors:  H S Garewal; R Sampliner; D Alberts; K Steinbronn
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

Review 6.  Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.

Authors:  Eugene W Gerner; Elizabeth Bruckheimer; Alfred Cohen
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

Review 7.  Applications of inulin and oligofructose in health and nutrition.

Authors:  Narinder Kaur; Anil K Gupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

8.  Inhibition of gastric tumorigenesis by alpha-difluoromethylornithine in rats treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  T Lehnert; K Buhl; S Ivankovic
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Cell kinetics and polyamine enzymes in the intestinal mucosa of rats with azoxymethane induced tumours.

Authors:  C Pizzi; S Pignata; R Calderopoli; L D'Agostino; G Tritto; G D'Adamo; G Esposito; B Daniele; G Mazzacca; A R Bianco
Journal:  Int J Exp Pathol       Date:  1994-10       Impact factor: 1.925

10.  Effect of difluoromethylornithine (DFMO) on NSAID-induced intestinal injury in rats.

Authors:  R A Erickson; N Rivera
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.